Thallium scintigraphy compared with 18f-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction

Myocardial Viability ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Severe Left Ventricular Dysfunction ◽

Positron Emission ◽

The Extent of Perfusion–F18-Fluorodeoxyglucose Positron Emission Tomography Mismatch Determines Mortality in Medically Treated Patients With Chronic Ischemic Left Ventricular Dysfunction

10.1016/j.jacc.2005.06.057 ◽

2005 ◽

Vol 46 (7) ◽

pp. 1264-1269 ◽

Cited By ~ 63

Author(s):

Alessandro Desideri ◽

Lauro Cortigiani ◽

Alejandra Ines Christen ◽

Sebastian Coscarelli ◽

Dario Gregori ◽

...

Keyword(s):

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Positron Emission ◽

Positron emission tomography using18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of18F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability

European Heart Journal ◽

10.1053/euhj.2000.2585 ◽

2001 ◽

Vol 22 (18) ◽

pp. 1691-1701 ◽

Cited By ~ 59

Author(s):

B Gerber

Keyword(s):

European Community ◽

Myocardial Viability ◽

Multicenter Study ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Concerted Action ◽

Positron Emission

577 The role of fluorodeoxyglucose positron emission tomography guided management in improving quality of life amongst patients with ischemic left ventricular dysfunction

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2011.07.477 ◽

2011 ◽

Vol 27 (5) ◽

pp. S269-S270

Author(s):

T. Shukla ◽

G. Nichol ◽

G. Wells ◽

L. Garrard ◽

A. Guo ◽

...

Keyword(s):

Quality Of Life ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Positron Emission ◽

F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease

10.1016/j.jacc.2007.09.006 ◽

2007 ◽

Vol 50 (20) ◽

pp. 2002-2012 ◽

Cited By ~ 270

Author(s):

Rob S.B. Beanlands ◽

Graham Nichol ◽

Ella Huszti ◽

Dennis Humen ◽

Normand Racine ◽

...

Keyword(s):

Ventricular Dysfunction ◽

Positron Emission Tomography Imaging ◽

Left Ventricular ◽

Emission Tomography ◽

Severe Left Ventricular Dysfunction ◽

Tomography Imaging ◽

Positron Emission ◽

Assisted Management ◽

DOES FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY GUIDED MANAGEMENT IMPROVE QUALITY OF LIFE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION? A QUALITY OF LIFE SUBSTUDY OF THE PARR2 TRIAL

10.1016/s0735-1097(11)60799-7 ◽

2011 ◽

Vol 57 (14) ◽

pp. E799

Author(s):

Tushar Shukla ◽

Graham Nichol ◽

George Wells ◽

Linda Garrard ◽

Ann Guo ◽

...

Keyword(s):

Quality Of Life ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Improve Quality ◽

Positron Emission ◽

Positron Emission Tomography And Recovery following Revascularization: Outcomes and Cost-Effectiveness using F-18-fluorodeoxyglucose (FDG) PET in Severe Left Ventricular Dysfunction (PARR Phase 2)

http://isrctn.org/> ◽

10.1186/isrctn00827330 ◽

2012 ◽

Author(s):

Rob Beanlands

Keyword(s):

Cost Effectiveness ◽

Fdg Pet ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Phase 2 ◽

Severe Left Ventricular Dysfunction ◽

Positron Emission

Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction. A clinical study using positron emission tomography, echocardiography and electrocardiography

ACC Current Journal Review ◽

10.1016/j.accreview.2004.07.069 ◽

2004 ◽

Vol 13 (8) ◽

pp. 25-26

Author(s):

H. Yang ◽

M. Pu ◽

D. Rodriguez

Keyword(s):

Myocardial Infarction ◽

Clinical Study ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Viable Myocardium ◽

Emission Tomography ◽

Positron Emission ◽

Q Wave

Manganese-enhanced T1 mapping to quantify myocardial viability: validation with 18F-fluorodeoxyglucose positron emission tomography

Scientific Reports ◽

10.1038/s41598-020-58716-x ◽

2020 ◽

Vol 10 (1) ◽

Cited By ~ 3

Author(s):

Nick Spath ◽

Adriana Tavares ◽

Gillian A. Gray ◽

Andrew H. Baker ◽

Ross J. Lennen ◽

...

Keyword(s):

Myocardial Viability ◽

T1 Mapping ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction

10.1016/0735-1097(96)00069-1 ◽

1996 ◽

Vol 27 (7) ◽

pp. 1601-1607 ◽

Cited By ~ 23

Author(s):

Robert K.M. Chan ◽

Kenneth J. Lee ◽

Paul Calafiore ◽

Salvatore U. Berlangieri ◽

W. John McKay ◽

...

Keyword(s):

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Dobutamine Echocardiography ◽

Positron Emission

Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction

The American Journal of Cardiology ◽

10.1016/0002-9149(94)90327-1 ◽

1994 ◽

Vol 73 (8) ◽

pp. 527-533 ◽

Cited By ~ 329

Author(s):

Marcelo F. Di Carli ◽

Michael Davidson ◽

Roderick Little ◽

Sandeep Khanna ◽

Freny V. Mody ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Emission Tomography ◽

Metabolic Imaging ◽

Positron Emission ◽

Artery Disease